They constructed a mouse model of intracranial in situ glioblastoma and administered whole brain irradiation at a dose of 12 Gy or in combination with PLX3397 (a small molecule CSF-1R tyrosinase activity inhibitor). This evidence concerns the gene CSF1R and glioblastoma.